5265

    543322

    ALIVUS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ALIVUS LIFE SCIENCES LTD Share Price Today

    ALIVUS LIFE SCIENCES LTD is currently trading at ₹1153.6, up by ₹23.5 from the previous close. The stock touched an intraday high of ₹1171.00 and a low of ₹1130.10 during the latest trading session. Over the past one year, ALIVUS LIFE SCIENCES LTD has delivered a return of 11.7%, while the stock has gained 12.78% in the last one month.

    ALIVUS LIFE SCIENCES LTD performance

    Today’s low Today’s high
    ₹ 1130.10 ₹ 1171.00
    ₹ 1130.10
    52 week low 52 week high
    ₹ 819.00 ₹ 1193.90
    ₹ 1130.10
    Open Price ₹ 1135.30
    Prev. Close ₹ 1130.10
    Volume (Shares) 162048.00
    Total traded value ₹ 1831.30
    Upper Circuit ₹ 1356.10
    Lower Circuit ₹ 904.10
    info

    Investment Returns

    Over 1 Month 12.78% Over 3 Months 8.22% Over 6 Months 25.11% Over 1 Year 11.70%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ALIVUS LIFE SCIENCES LTD fundamentals


    • Market cap (Cr) 13,870.80
    • P/E Ratio (TTM) 24.50
    • Beta 0.54
    • Book Value / share 271.48
    • Return on equity 18.86%
    • EPS (TTM) 47.56
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 162.66
    info icon alternate text
    • Market cap (Cr) 14,115.00
    • P/E Ratio (TTM) 24.50
    • Beta 0.49
    • Book Value / share 271.48
    • Return on equity 18.86%
    • EPS (TTM) 47.56
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 162.66
    info icon alternate text

    ALIVUS LIFE SCIENCES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 689.12
    Operating Expense 496.10
    Net Profit 162.66
    Net Profit Margin (%) 23.60
    Earnings Per Share (EPS) 13.23
    EBITDA 237.31
    Effective Tax Rate (%) 24.62
    Particulars DEC 2025 (Values in Cr)
    Revenue 672.89
    Operating Expense 462.76
    Net Profit 150.26
    Net Profit Margin (%) 22.33
    Earnings Per Share (EPS) 12.25
    EBITDA 219.54
    Effective Tax Rate (%) 24.26
    Particulars SEP 2025 (Values in Cr)
    Revenue 587.98
    Operating Expense 428.57
    Net Profit 130.03
    Net Profit Margin (%) 22.11
    Earnings Per Share (EPS) 10.60
    EBITDA 193.89
    Effective Tax Rate (%) 25.33
    Particulars JUN 2025 (Values in Cr)
    Revenue 601.85
    Operating Expense 447.85
    Net Profit 121.54
    Net Profit Margin (%) 20.19
    Earnings Per Share (EPS) 9.91
    EBITDA 181.29
    Effective Tax Rate (%) 25.43
    Particulars MAR 2025 (Values in Cr)
    Revenue 649.55
    Operating Expense 468.34
    Net Profit 141.87
    Net Profit Margin (%) 21.84
    Earnings Per Share (EPS) 11.57
    EBITDA 208.51
    Effective Tax Rate (%) 25.83
    Particulars MAR 2026 (Values in Cr)
    Revenue 2551.83
    Operating Expense 1835.28
    Net Profit 564.48
    Net Profit Margin (%) 22.12
    Earnings Per Share (EPS) 45.99
    EBITDA 832.04
    Effective Tax Rate (%) 24.86
    Particulars MAR 2025 (Values in Cr)
    Revenue 2386.88
    Operating Expense 1767.32
    Net Profit 485.63
    Net Profit Margin (%) 20.34
    Earnings Per Share (EPS) 39.63
    EBITDA 717.15
    Effective Tax Rate (%) 25.75
    Particulars MAR 2024 (Values in Cr)
    Revenue 2283.21
    Operating Expense 1663.97
    Net Profit 470.89
    Net Profit Margin (%) 20.62
    Earnings Per Share (EPS) 38.43
    EBITDA 686.29
    Effective Tax Rate (%) 25.40
    Particulars MAR 2023 (Values in Cr)
    Revenue 2161.22
    Operating Expense 1561.57
    Net Profit 466.96
    Net Profit Margin (%) 21.60
    Earnings Per Share (EPS) 38.11
    EBITDA 671.25
    Effective Tax Rate (%) 25.71
    Particulars MAR 2022 (Values in Cr)
    Revenue 2123.21
    Operating Expense 1572.99
    Net Profit 418.72
    Net Profit Margin (%) 19.72
    Earnings Per Share (EPS) 35.63
    EBITDA 630.77
    Effective Tax Rate (%) 25.87
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 229.92
    ROE % 18.86
    ROCE % 24.97
    Total Debt to Total Equity 0.01
    EBITDA Margin 30.05
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 190.35
    ROE % 21.07
    ROCE % 27.94
    Total Debt to Total Equity 0.01
    EBITDA Margin 30.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 174.51
    ROE % 22.28
    ROCE % 29.80
    Total Debt to Total Equity 0.01
    EBITDA Margin 31.06
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 167.66
    ROE % 29.83
    ROCE % 42.20
    Total Debt to Total Equity 0.00
    EBITDA Margin 29.71
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 768.11
    ROE % 60.91
    ROCE % 96.75
    Total Debt to Total Equity 0.00
    EBITDA Margin 31.40
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 71.23
    Total Assets 3411.45
    Total Liabilities 3411.45
    Total Equity 2817.37
    Share Outstanding 12
    Price to Book Ratio 4.70
    Return on Assets (%) 14.23
    Return on Capital (%) 17.24
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 301.59
    Total Assets 2850.41
    Total Liabilities 2850.41
    Total Equity 2332.32
    Share Outstanding 12
    Price to Book Ratio 4.07
    Return on Assets (%) 16.51
    Return on Capital (%) 20.19
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 309.39
    Total Assets 2702.14
    Total Liabilities 2702.14
    Total Equity 2138.20
    Share Outstanding 12
    Price to Book Ratio 2.24
    Return on Assets (%) 17.28
    Return on Capital (%) 21.84
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 512.16
    Total Assets 2471.00
    Total Liabilities 2471.00
    Total Equity 2054.31
    Share Outstanding 12
    Price to Book Ratio 2.74
    Return on Assets (%) 16.94
    Return on Capital (%) 20.38
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 115.59
    Total Assets 1997.07
    Total Liabilities 1997.07
    Total Equity 752.74
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 17.60
    Return on Capital (%) 46.71
    Particulars MAR 2025 (Values in Cr)
    Net Income 654.13
    Cash from Operations 554.47
    Cash from Investing -615.64
    Cash from Financing -6.23
    Net change in Cash -230.35
    Free Cash Flow 720.66
    Particulars MAR 2024 (Values in Cr)
    Net Income 631.29
    Cash from Operations 576.47
    Cash from Investing -116.48
    Cash from Financing -279.44
    Net change in Cash 17.59
    Free Cash Flow 705.44
    Particulars MAR 2023 (Values in Cr)
    Net Income 628.60
    Cash from Operations 459.57
    Cash from Investing -146.74
    Cash from Financing -387.59
    Net change in Cash -228.33
    Free Cash Flow 622.36
    Particulars MAR 2022 (Values in Cr)
    Net Income 564.92
    Cash from Operations 735.75
    Cash from Investing -122.22
    Cash from Financing -78.79
    Net change in Cash 396.56
    Free Cash Flow 867.92
    Particulars MAR 2021 (Values in Cr)
    Net Income 470.94
    Cash from Operations 496.67
    Cash from Investing -68.73
    Cash from Financing -213.78
    Net change in Cash 105.59
    Free Cash Flow 564.67
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 31.48 13.06 1.52 241.24 23.12 38.85
    BLISS GVS PHARMA LTD 509.15 40.93 4.52 5399.85 118.35 552.90
    CIPLA LTD. 1431.65 30.38 3.35 115655.17 1165.55 1672.20
    FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2409.90 42.43 18.00 40825.16 2088.00 3343.05
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 31.48 22.01 4.05 241.24 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8150.15 106.44 23.34 20375.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 509.15 55.04 4.67 5399.85 118.35 552.90

    ALIVUS LIFE SCIENCES LTD shareholding pattern

    Holding
    12.55%
    74.87%
    5.29%
    7.27%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ALIVUS LIFE SCIENCES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1130.10 0.00 redarrow
    red-green-graph indicator
    5 Bearish
    11 Bullish
    • 5 Days 1145.80
    • 26 Days 1098.60
    • 10 Days 1131.90
    • 50 Days 1072.30
    • 12 Days 1126.10
    • 100 Days 1034.80
    • 20 Days 1107.90
    • 200 Days 1005.20
    1146.70 PIVOT
    First Support 1099.50 First Resistance 1177.30 Second Support 1068.90 Second Resistance 1224.50 Third Support 1021.70 Third Resistance 1255.10
    RSI 63.54 ADX 22.63 MACD 27.48 Williams % R -32.24 Commodity Channel Index (CCI) 83.24
    Date 2026-07-08 Week 67982.00 Same Day 45084.00 Month 59525.00
    1 Year 0.55 3 Year 0.48
    Over 1 Month
    12.78% down
    Over 1 Year
    11.70% down
    Over 3 Months
    8.22% down
    Over 3 Years
    24.72% down
    Over 6 Months
    25.11% down
    Over 5 Years
    8.58% down

    ALIVUS LIFE SCIENCES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    01 Sep 2025 5.0 Final 01 Sep 2025 Equity shares
    17 Oct 2023 22.5 Interim 17 Oct 2023 Equity shares
    24 Mar 2023 21.0 Interim 24 Mar 2023 Equity shares
    15 Sep 2022 10.5 Final 17 Sep 2022 Equity shares
    22 Nov 2021 10.5 Interim 23 Nov 2021 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    01 Sep 2025 5.0 Final 01 Sep 2025 Equity shares
    17 Oct 2023 22.5 Interim 17 Oct 2023 Equity shares
    24 Mar 2023 21.0 Interim 24 Mar 2023 Equity shares
    15 Sep 2022 10.5 Final 17 Sep 2022 Equity shares
    22 Nov 2021 10.5 Interim 23 Nov 2021 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Alivus Life Sciences Ltd?

    Answer Field

    Alivus Life Sciences Ltd share price is for NSE ₹ 1,153.60 & for BSE ₹ 1,153.60 as on Jul 09 2026 10:59 AM.

    What is the Market Cap of Alivus Life Sciences Ltd Share?

    Answer Field

    The market cap of Alivus Life Sciences Ltd for NSE ₹ 13,870.80 & for BSE ₹ 0.00 as on Jul 09 2026 10:59 AM.

    What is the 52 Week High and Low of Alivus Life Sciences Ltd?

    Answer Field

    The 52 Week High and Low of Alivus Life Sciences Ltd for NSE is ₹ 1,193.90 and ₹ 819.00 and for BSE is ₹ 1,193.30 and ₹ 0.00.

    What is 1 year return for Alivus Life Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 11.70%.

    What is the P/E Ratio of Alivus Life Sciences Ltd Share?

    Answer Field

    As on Jul 09 2026 10:59 AM the price-to-earnings (PE) ratio for Alivus Life Sciences Ltd share is 24.50.

    What is the PB ratio of Alivus Life Sciences Ltd Share?

    Answer Field

    As on Jul 09 2026 10:59 AM, the price-to-book (PB) ratio for Alivus Life Sciences Ltd share is 271.48.

    How to Buy Alivus Life Sciences Ltd Share?

    Answer Field

    You can trade in Alivus Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Alivus Life Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Alivus Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Alivus Life Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |